Question 1

What is CME Group's P/S ratio?

Accepted Answer

CME Group (CME) P/S ratio is 13.3× as of July 22, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for CME Group?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For CME Group specifically, the relevant sector benchmark is the current sector median of 2.3×.

Question 5

Is CME Group's P/S ratio high or low?

Accepted Answer

CME Group's P/S ratio of 13.3× is below its own 5-year average of 14.3× and above the sector median of 2.3×. That places the current reading at the 22th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is CME Group's historical P/S ratio range?

Accepted Answer

In the available daily series, CME Group (CME) P/S ratio has ranged from a low of 2.7× in 2002 to a high of 20.9× in 2007. The 5-year average is 14.3× and the 5-year median is 13.6×.

Question 7

What was CME Group's P/S ratio in 2025?

Accepted Answer

CME Group (CME) P/S ratio at the end of 2025 was 15.1×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does CME Group's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$98.2B	$6.52B	15.1×	+1.4×	Dec 31, 2025
2024	$83.5B	$6.13B	13.6×	+0.1×	Dec 31, 2024
2023	$75.6B	$5.58B	13.6×	+1.5×	Dec 31, 2023
2022	$60.4B	$5.02B	12.0×	-5.4×	Dec 31, 2022
2021	$81.9B	$4.69B	17.5×	+4.1×	Dec 31, 2021
2020	$65.2B	$4.88B	13.3×	-1.4×	Dec 31, 2020
2019	$71.7B	$4.87B	14.7×	-0.6×	Dec 31, 2019
2018	$66B	$4.31B	15.3×	+1.7×	Dec 31, 2018
2017	$49.5B	$3.64B	13.6×	+2.7×	Dec 31, 2017
2016	$39B	$3.6B	10.8×	+1.7×	Dec 31, 2016
2015	$30.5B	$3.33B	9.2×	-0.4×	Dec 31, 2015
2014	$29.7B	$3.11B	9.5×	+0.6×	Dec 31, 2014
2013	$26.2B	$2.94B	8.9×	+3.1×	Dec 31, 2013
2012	$16.8B	$2.91B	5.8×	+0.9×	Dec 31, 2012
2011	$16.1B	$3.28B	4.9×	-2.2×	Dec 31, 2011
2010	$21.5B	$3B	7.2×	-1.4×	Dec 31, 2010
2009	$22.3B	$2.61B	8.5×	+3.7×	Dec 31, 2009
2008	$12.5B	$2.56B	4.9×	-13.8×	Dec 31, 2008
2007	$32.8B	$1.76B	18.7×	+2.4×	Dec 31, 2007
2006	$17.7B	$1.09B	16.3×	+2.8×	Dec 31, 2006
2005	$12.7B	$938M	13.5×	+3.2×	Dec 31, 2005
2004	$7.77B	$753M	10.3×	+5.9×	Dec 31, 2004
2003	$2.38B	$536M	4.4×	+1.4×	Dec 31, 2003
2002	$1.42B	$469M	3.0×	—	Dec 31, 2002


Citigroup (C)	1.5×
W. R. Berkley (WRB)	1.5×
American International Group (AIG)	1.5×
Capital One Financial (COF)	1.5×
Travelers Companies (TRV)	1.4×
Federal Agricultural Mortgage (AGM)	1.4×
Franklin Resources (BEN)	1.4×
Brookfield (BN)	1.3×
American Financial Group (AFG)	1.3×
Hartford Insurance Group (HIG)	1.3×
Markel (MKL)	1.3×
PSB Holdings (PSBQ)	1.3×
Principal Financial Group (PFG)	1.3×
PayPal (PYPL)	1.2×
Loews (L)	1.2×
AXIS Capital Holdings (AXS)	1.1×
Old Republic International (ORI)	1.0×
Assurant (AIZ)	0.8×
Allstate (ALL)	0.8×
Mercury General (MCY)	0.8×
Everest Group (EG)	0.8×
MetLife (MET)	0.6×
Prudential Financial (PRU)	0.5×
StoneX Group (SNEX)	0.0×
Atlantic Union Bankshares (AUB)	0.0×

P/S Ratio for CME Group (CME) 2002-2026

P/S Ratio daily chart for CME Group (CME)

Historical P/S Ratio for CME Group (CME) from 2002 to 2025

About P/S Ratio at CME Group (CME)

CME Group P/S Ratio by Year

CME Group P/S Ratio 2025: 15.1×

CME Group P/S Ratio 2024: 13.6×

CME Group P/S Ratio 2023: 13.6×

CME Group P/S Ratio 2022: 12.0×

CME Group P/S Ratio 2021: 17.5×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

CME Group (CME) Key Financials